2018 annual financial data

4D Molecular Therapeutics 2018 Financial results

4D Molecular Therapeutics 2018 financial results with verified reported values.

Direct answer

Revenue was 14,130,000 USD.

Operating income was -10,399,000 USD and net income was -9,551,000 USD.
Operating cash flow was -16,252,000 USD.

Get free 4D Molecular Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
14,130,000 USD
Operating income
-10,399,000 USD
Net income
-9,551,000 USD
Operating cash flow
-16,252,000 USD